Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prognostic impact of early oseltamivir carboxylate underdosing in ICU patients with severe influenza
2022-002377-28Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oseltamivir and acetaminophen in influenza (2 cohorts), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Number of days alive without invasive mechanical ventilation at day 28. Started Jul 2022; status: active.
02
Drugs
oseltamiviracetaminophen
03
Conditions
influenza
Beyond the preview
Go deeper on 2022-002377-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002377-28.